1. Introduction {#s0005}
===============

Every year, approximately 6.7 million deaths take place around the world due to various types of cancer ([@b0010]). A wide array of cytotoxic agents and radiotherapy used in the cancer treatment have limitations in their usage e.g. side effects, and efficacy ([@b0055], [@b0085]); therefore, the development of better effective therapeutics for the cancer treatment from natural products remain continues because of its minimal side effects ([@b0025], [@b0090], [@b0030]).

Although *Adenium obesum* (Forssk.) Roem. & Schult. (family Apocynaceae, commonly known as 'Desert Rose') is primarily an ornamental poisonous plant, the whole plant including latex has been used in traditional system of medicines for the treatment of various aliments e.g. skin lumps, wound, ear ache, rhinitis, gonorrhea and infectious diseases. It contains nearly 50 major chemicals constituents belonging to the class of cardenolides, flavonoids, pregnanes and triterpenes ([@b0095]). The recent reports ([@b0020], [@b0045], [@b0005], [@b0015]) established the anticancer activity of extract of aerial part of *A. obesum* but the modes of action of the chemical constituents have not been understood; therefore, the aim of the current study is to elucidate the plausible molecular mechanisms underlying the anticancer activity of *A. obesum* extract using *in silico* approaches.

2. Materials and methods {#s0010}
========================

2.1. Preparation of ligand and receptor {#s0015}
---------------------------------------

The structures of nine major compounds of *A. obesum* ([Table 1](#t0005){ref-type="table"}) were modeled using Chemsketch. The three-dimensional structures of selected macromolecular receptors e.g. (i) CDK-2 \[PDB ID: 1DI8\], (ii) CDK-6 \[PDB ID: 1XO2\], (iii-iv) Topoisomerases-I \[PDB ID: 1T8I\] and II \[PDB ID: 1ZXM\], (v) BCL-2 \[PDB ID: 2O2F\], (vi) VEGFR-2 \[PDB ID: 2OH4\], and (vii) Telomere: G-quadruplex \[1L1H\] were retrieved from Protein Data Bank (PDB). The 3-D structures of ligands optimized with MMFF94 force field ([@b0040]), and the receptors prepared following our previously described method ([@b0035]) were used to execute docking. The binding sites were defined by choosing grid boxes of suitable dimensions around the bound co-crystal ligands.Table 1The major compounds derived from *A. obesum* selected for molecular docking.CompoundsNameStructureClassPartsReferences1Δ^16^-3-Acetyldigitoxigenin (16-anhydro-3-acetylgitoxigenin)![](fx1.gif)Cardiac glycosidesStemVethaviyasar and John (1982)212β-Hydroxypregna-4,6,16-triene-3,20-dione (neridienoneA)![](fx2.gif)PregnanesStem, roots, leavesYamauchi and Abe (1990)\
Nakamura et al. (2000)312β-Hydroxypregna-4,6-diene-3,20-dione\
(16,17-dihydroneridienone A)![](fx3.gif)PregnanesStem, roots, leavesYamauchi and Abe (1990)\
Nakamura et al. (2000)412β-Hydroxpregna-4,16-diene-3,20-dione![](fx4.gif)PregnanesLeavesNakamura et al. (2000)512β-Hydroxypregn-4-ene-3,20-dione![](fx5.gif)PregnanesLeavesNakamura et al. (2000)6Dihydroifflaionic acid![](fx6.gif)TriterpenoidsAerialHoffmann and Cole (1977)7Lup-20(29)-ene-3,28-diol (betulin)![](fx7.gif)TriterpenoidsStem barkTijjani et al. (2012)8Quercetin 3,3′-dimethyl ether![](fx8.gif)FlavonoidsAerialHoffmann and Cole (1977)9Kaempferol 3-methyl ether![](fx9.gif)FlavonoidsAerialHoffmann and Cole (1977)

2.2. Molecular docking {#s0020}
----------------------

The Lamarckian Genetic Algorithm was used for performing molecular docking using AutoDock4.2 ([@b0070]) considering the docking parameters from our previously described method ([@b0035]). A total number of 50 independent docking runs were performed for each ligand. The conformations were grouped under clusters by considering a difference of less than 2.0 Å of root mean square deviation (RMSD). The lowest free energy of binding (ΔG) and the lowest inhibition constant (K~i~) were considered for choosing the most favorable binding pose. The molecular interactions between the compounds and receptors were studied using LigPlot + v 1.4.5 ([@b0060]).

2.3. Validation of docking method {#s0025}
---------------------------------

In order to check the suitability of molecular docking parameters and algorithm to reproduce the native binding poses, redocking experiment was performed using the co-crystal ligands.

2.4. Determination of physicochemical properties of the compounds {#s0030}
-----------------------------------------------------------------

DataWarrior program version 4.6.1 was used for the determination of various physicochemical properties of the selected compounds such as drug likeness and toxicity ([@b0080]).

3. Results and discussion {#s0035}
=========================

The three dimensional structure of nine major compounds \[Δ16-3-Acetyldigitoxigenin (16-anhydro-3-acetylgitoxigenin), 12β-Hydroxypregna-4,6,16-triene-3,20-dione (neridienoneA), 12β-Hydroxypregna-4,6-diene-3,20-dione (16,17-dihydroneridienone A), 12β-Hydroxpregna-4,16-diene-3,20-dione, 12β-Hydroxypregn-4-ene-3,20-dione, Dihydroifflaionic acid, Lup-20(29)-ene-3,28-diol (betulin), Quercetin 3,3′-dimethyl ether, Kaempferol 3-methyl ether\] from *A. obesum* were modeled and optimized. The optimized structures were used further for molecular docking studies ([Table 1](#t0005){ref-type="table"}). Before performing molecular docking studies, we validated the docking protocol and algorithm through redocking experiment. In all the cases, the root mean square deviation (RMSD) between the docked and native co-crystal position were found to be less than 2 Å. This indicates that the docking protocols, and parameters employed in the present study can reliably predict the native conformations of the compounds ([@b0050]).

The results of molecular docking are shown in [Table 2](#t0010){ref-type="table"}. It is evident that compound 1 \[(Δ^16^-3-Acetyldigitoxigenin (16-anhydro-3-acetylgitoxigenin)\] was best docked to CDK-2 with ΔG of −11.39 kcal/mol and K~i~ of 4.50 nM, which is significantly lower than the co-crystal ligand having ΔG of −8.04 kcal/mol and K~i~ of 1270 nM. LigPlot + results as shown in [Fig. 1](#f0005){ref-type="fig"} indicates that the compound 1 was able to establish four hydrogen bonds through Lys33, Leu83 and Lys89. Further, this binding was strengthened by hydrophobic interactions with Ile10, Val18, Ala31, Val64, Phe80, Glu81, Phe82, His84, Gln85, Asp86, Leu134, Ala144, Asp145 and Leu148.Table 2The binding energies and inhibition constants of selected compounds derived from *A. obesum* docked against molecular targets.CompoundsDrug targets (PDB Entries)CDK-2 (1DI8)CDK-6 (1XO2)Topoisomerase-II (1ZXM)BCL-2 (2O2F)VEGFR-2 (2OH4)Telomere: G-quadruplex (1L1H)Topoisomerase-I (1T8I)BE (kcal/mol)K~i~(nM)BE (kcal/mol)K~i~(nM)BE (kcal/mol)K~i~(nM)BE (kcal/mol)K~i~(nM)BE (kcal/mol)Ki(nM)BE (kcal/mol)K~i~(nM)BE (kcal/mol)K~i~(nM)1−11.394.50−8.93282.69−11.454.03−8.47618.23−10.1735.14−5.6177,660−10.949.492−10.1039.54−10.1139.13−9.05231.69−8.23923.49−9.7473.07−7.552940−9.13201.633−10.0146.25−9.9947.72−8.96268.59−8.23933.55−9.21177.53−7.304470−9.34143.284−10.0642.53−9.9649.96−8.98262.49−8.24905.38−8.73401.36−7.383920−9.8164.685−9.9848.73−10.0344.34−8.84333.04−8.37736.14−9.29154.49−7.433570−9.6978.716−11.206.20−6.0238,380−7.951490−8.55540.37−8.41679.17−6.2625,950−9.8263.217−10.3028.15−6.4319,240−9.40129.67−8.73400.37−7.971430−7.354100−9.6585.118−8.30819.79−9.20181.34−7.423640−5.9543.29−9.11211.74−8.92287.67−9.03240.579−7.742110−9.05232.35−7.205280−6.0536,840−8.69426.31−8.46628.78−8.61487.63Co-crystal ligand−8.041270−8.26882.71−11.117.24−11.018.56−12.460.738−11.971.68−10.7513.23Fig. 1The binding modes and LigPlot + results for receptor-ligand interactions. The molecular interaction between: CDK-2 and Δ^16^-3-Acetyldigitoxigenin (16-anhydro-3-acetylgitoxigenin) (A); CDK-6 and 12β-Hydroxypregna-4,6,16-triene-3,20-dione (neridienoneA) (B); Topoisomerase-II and Δ^16^-3-Acetyldigitoxigenin (16-anhydro-3-acetylgitoxigenin) (C); BCL-2 and Lup-20(29)-ene-3,28-diol (betulin) (D); VEGFR-2 and Δ^16^-3-Acetyldigitoxigenin (16-anhydro-3-acetylgitoxigenin) (E); Telomere: G-quadruplex and Quercetin 3,3′-dimethyl ether (F); Topoisomerase-I and Δ^16^-3-Acetyldigitoxigenin (16-anhydro-3-acetylgitoxigenin) (G). The hydrogen bonds are represented by green dashed lines with the bond distance. The residues contributing to the hydrophobic interactions are indicated with red arcs with spikes.

The compound 2 \[12β-Hydroxypregna-4,6,16-triene-3,20-dione (neridienoneA)\] was best docked to CDK-6 with a binding energy of −10.11 kcal/mol and K~i~ of 39.13 nM, which is much lower than the co-crystal ligand having binding energy −8.26 kcal/mol and K~i~ of 882.71 nM. It formed three hydrogen bonds with Lys43, His100, Val101 and residues involved in hydrophobic interactions include Ile19, Asp102, Gln103, Asp104, Gln149, Leu152, Ala162 and Asp163. Again, compound 1 \[(Δ^16^-3-Acetyldigitoxigenin (16-anhydro-3-acetylgitoxigenin)\] was found to be best docked to Topoisomerase-II with a binding energy of −11.45 and K~i~ of 4.03 nM which is slightly lower than the co-crystal ligand having a binding energy of −11.11 kcal/mol and K~i~ of 7.24 nM. It formed five hydrogen bonds with Arg98, Asn120, Asn163, Gly164 and Lys378 and hydrophobic interaction with residues Glu87, Asn91, Asn95, Lys123, Ile125, Ile141, Phe142, Ser148, Asn150, Gly161, Arg162, Tyr165, Gly166, Ala167, Thr215 and Gln376.

The best docked compound for BCL-2 was found to be compound 7 \[Lup-20(29)-ene-3,28-diol (betulin)\] with a binding energy of −8.73 kcal/mol and K~i~ of 400.37 nM which was found to higher than the co-crystal ligand with a binding energy of −11.01 kcal/mol and K~i~ of 8.56 nM. It was able to establish only one hydrogen bond with Tyr105 and hydrophobic interactions with residues Phe101, Asp108, Phe109, Met112, Leu134, Gly142, Arg143 and Ala146. Compound 1 \[(Δ^16^-3-Acetyldigitoxigenin (16-anhydro-3-acetylgitoxigenin)\] was also best docked to VEGFR-2 with a binding energy of −10.17 kcal/mol and K~i~ of 35.14 nM which was found to be higher than the co-crystal ligand with binding energy of −12.46 kcal/mol and K~i~ of 0.738 nM. It showed good interaction with VEGFR-2 through one hydrogen bond with residue Glu915 and hydrophobic interaction via residues Leu838, Ala864, Glu883, Val897, Val914, Phe916, Cys917, Gly920, Leu1033, Cys1043, Asp1044 and Phe1045.

The best docked ligand for Telomere:G-quadruplex was compound 8 \[Quercetin 3,3′-dimethyl ether\] with a binding energy of −8.92 kcal/mol and K~i~ of 287.67 nM which was significantly higher than the co-crystal ligand with a binding energy of −11.97 kcal/mol and K~i~ of 1.68 nM. Compound 8 \[Quercetin 3,3′-dimethyl ether\] formed two hydrogen bonds with bases DT1006 and DG1009 and hydrophobic interactions via bases Dt1007, Dt1008, Dg2001 and Dg2012. Compound 1 \[(Δ^16^-3-Acetyldigitoxigenin (16-anhydro-3-acetylgitoxigenin)\] is also best docked to Topoisomerase-I with a binding energy of −10.94 kcal/mol and K~i~ of 9.49 nM which is slightly lower than the co-crystal ligand with a binding energy of −10.75 kcal/mol and Ki of 13.23 nM. It formed three hydrogen bonds with Asn419, Ile420, Met428 and hydrophobic interactions via residues Asn352, Glu356, Lys374, Arg375, Trp416, Glu418, Lys425, Tyr426 and Ile427.

The physicochemical properties of the docked compounds are tabulated in [Table 3](#t0015){ref-type="table"}. The majority of the compounds obeyed the Lipinski's rule of five (ROF) ([@b0065]) except for compounds 6 \[Dihydroifflaionic acid\] and 7 \[Lup-20(29)-ene-3,28-diol (betulin)\] which showed one violation as their cLogP values were higher than the permissible limits. Compounds 1 \[Δ^16^-3-Acetyldigitoxigenin (16-anhydro-3-acetylgitoxigenin)\], 6 \[Dihydroifflaionic acid\], 7 \[Lup-20(29)-ene-3,28-diol (betulin)\], 8 \[Quercetin 3,3′-dimethyl ether\] and 9 \[Kaempferol 3-methyl ether\] were found to be non-mutagenic, non-tumorigenic, non-irritant and without any adverse effects on reproductive health. Compounds 2 \[12β-Hydroxypregna-4,6,16-triene-3,20-dione (neridienoneA)\], 3 \[12β-Hydroxypregna-4,6-diene-3,20-dione (16,17-dihydroneridienone A)\], 4 \[12β-Hydroxpregna-4,16-diene-3,20-dione\] and 5 \[12β-Hydroxypregn-4-ene-3,20-dione\] also showed similar results except for their possible toxicity on reproductive health. The majority of the compounds showed a good drug likeness score except for compounds 1 \[Δ^16^-3-Acetyldigitoxigenin (16-anhydro-3-acetylgitoxigenin)\], 6 \[Dihydroifflaionic acid\] and 7 \[Lup-20(29)-ene-3,28-diol (betulin)\] which exhibited negative drug likeness score. The other physicochemical properties such as topological surface area (TPSA) and number of rotatable bonds (RB) were also found to be within permissible limits (TPSA ≤ 140 Å^2^ and RB ≤ 10).Table 3The physicochemical properties of the compounds derived from *A. obesum* \[- (none), h (high)\].CompoundsMol weightcLogPcLogSHBAHBDTPSADrug likenessMutagenicTumorigenicReproductive EffectiveIrritancyRotatable Bonds1414.543.3025−4.4145172.83−0.27262--------32326.4342.787−3.6513154.371.9744----h--13328.452.8915−3.9153154.371.9131----h--14328.453.0624−3.8793154.371.9189--hh--15330.4663.1669−4.1433154.371.8595----h--16456.7086.0021−6.1113257.53−2.3517--------17442.7256.7202−6.2962240.46−23.933--------28331.2990.8411−2.16473113.291.5726--------39301.2730.9111−2.14663104.061.5726--------2

Thus, the present molecular docking studies revealed structural insights into possible binding modes of major active compounds of *A. obesum*, and identified the best docked compound for each target. The compound 1 (16-anhydro-3-acetylgitoxigenin) was found to be best docked (showed a high binding affinity, good number of hydrogen bonds and hydrophobic interactions with their respective molecular targets which play a key role in the pathogenesis of cancer) to four targets CDK-2, Topoisomerase-II, VEGFR-2 and Topoisomerase-I whereas Compound 2 (12β-Hydroxypregna-4,6,16-triene-3,20-dione), Compound 7 (Lup-20(29)-ene-3,28-diol) and Compound 8 (Quercetin 3,3′-dimethyl ether) were found to be best docked to CDK-6, BCL-2 and Telomere:G-quadruplex respectively with favorable drug-like properties; and thus, these compounds can be promising leads for the design of specific target inhibitors which would help with management of the disease.
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